Reformulated Ritalin winding through approval process; Novel topical foam earns a patent;

> Highland Therapeutics reformulated version of methylphenidate (marketed as Ritalin) dosed its first patient in one of its pivotal trials. The ADHD candidate is intended for nightime dosing so that symptoms are controllable during the morning routine. More

> The feds granted Nuvo Research a patent covering novel topical foam formulations that include dimethyl sulfoxide together with certain drug actives. The technology is an important part of its topical osteoarthritis drug, dubbed Pennsaid. More

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.